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On February 11, 2020 the World Health Organization announced an official name for the
disease that is causing the 2019 novel coronavirus outbreak, COVID-19. CDC will be updating
our website and other CDC materials to reflect the updated name.
Summary of Recent Changes
Revisions were made on February 10, 2020, to reflect the following:
The term “certified” was added to clarify that a certified Class II Biological Safety Cabinet (BSC) should be used for
any laboratory procedure with the potential to generate aerosols or droplets.
Additional details were provided for any laboratory procedures that are performed outside of a BSC.
Additional details were provided about the use of EPA-registered hospital disinfectants.
Additional details were provided for handling 2019-nCoV laboratory waste.
The need for both site- and activity-specific risk assessments was added to determine if additional laboratory
biosafety control measures are necessary.
February 10, 2020
Until more information becomes available, precautions should be taken in collecting and handling specimens that may
contain 2019-nCoV. Timely communication between clinical and laboratory staff is essential to minimize the risk incurred
in handling specimens from patients with possible 2019-nCoV infection. Such specimens should be labeled accordingly,
and the laboratory should be alerted to ensure proper specimen handling. General and specific biosafety guidelines for
handling 2019-nCoV specimens are provided below.
For additional detailed instructions please refer to the following:
Biosafety in Microbiological and Biomedical Laboratories (BMBL) – Fifth Edition
Laboratory Biosafety Manual – Third Editionexternal icon
General Guidelines (for working with potentially infectious
materials)
"
Laboratory workers should wear appropriate personal protective equipment (PPE) which includes disposable gloves,
laboratory coat/gown and eye protection when handling potentially infectious specimens.
Any procedure with the potential to generate aerosols or droplets (e.g., vortexing) should be performed in a certified
Class II Biological Safety Cabinet (BSC). Appropriate physical containment devices (e.g., centrifuge safety buckets; sealed
rotors) should be used for centrifugation. Ideally, rotors and buckets should be loaded and unloaded in a BSC. For any
procedures outside of a BSC, eye and face protection (e.g. goggles, mask, face shield) or other physical barriers (e.g.
splash shield) should be used to minimize the risk of exposure to laboratory staff.
After specimens are processed, decontaminate work surfaces and equipment with appropriate disinfectants. Use EPA-
registered hospital disinfectants with label claims to be effective against other respiratory pathogens, such as seasonal
influenza and other human coronaviruses. Follow manufacturer’s recommendations for use – dilution (i.e.,
concentration), contact time, and care in handling.
For 2019-nCoV laboratory waste, follow standard procedures associated with other respiratory pathogens, such as
seasonal influenza and other human coronaviruses.
Specific Guidelines
Virus isolation in cell culture and initial characterization of viral agents recovered in cultures of 2019-nCoV specimens are
NOT recommended at this time, except in a BSL3 laboratory using BSL3 work practices.
The following activities may be performed in BSL-2 facilities using standard BSL-2
work practices:
Pathologic examination and processing of formalin-fixed or otherwise inactivated tissues
Molecular analysis of extracted nucleic acid preparations
Electron microscopic studies with glutaraldehyde-fixed grids
Routine examination of bacterial and mycotic cultures
Routine staining and microscopic analysis of fixed smears
Final packaging of specimens for transport to diagnostic laboratories for additional testing. Specimens should
already be in a sealed, decontaminated primary container.
Inactivated specimens (e.g., specimens in nucleic acid extraction buffer)
The following activities involving manipulation of potentially infected specimens
should be, at a minimum, performed as above and in a certified Class II BSC in a
BSL-2 facility. Site- and activity-specific risk assessments should be performed to
determine if enhanced biosafety precautions are warranted based on situational
needs (e.g. high testing volumes):
Aliquoting and/or diluting specimens
Inoculating bacterial or mycological culture media
Performing diagnostic tests that do not involve propagation of viral agents in vitro or in vivo
Nucleic acid extraction procedures involving potentially infected specimens
Preparation and chemical- or heat-fixing of smears for microscopic analysis
Clinical Laboratory Testing
Clinical laboratories performing routine hematology, urinalysis, and clinical chemistry studies, and microbiology
laboratories performing diagnostic tests on serum, blood, or urine specimens should follow standard laboratory
practices, including Standard Precautions, when handling potential 2019-nCoV specimens. For additional information, see
Biosafety in Microbiological and Biomedical Laboratories (BMBL) – Fifth Edition (page 225).
Packing, Shipping and Transport
Packaging, shipping, and transport of specimens from suspect cases or PUI’s of 2019-nCoV infection must follow the
current edition of the International Air Transport Association (IATA) Dangerous Goods Regulations .
Follow shipping regulations for UN 3373 Biological Substance, Category B when sending potential 2019-nCoV specimens.
Resources
Packaging Checklist, see Category B Saf-T-Pak
Packing Instructions 650 for UN 3373
Click on “Infectious substances” and there is an option to download the packing instructions.
Labels for UN 3373
When using cold pack  – Include the name and telephone number of the person who will be available
during normal business hours who knows the content of the shipment (can be someone at CDC). Place the
label on one side of the box and cover the label completely with clear tape (do not tape just the edges of the
label).
When using dry ice  – Include the name and telephone number of the person who will be available during
normal business hours who knows the content of the shipment (can be someone at CDC). Place the label on
one side of the box and cover the label completely with clear tape (do not tape just the edges of the label).
Schematic for packaging, UN 3373 Category B
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